Head-To-Head Analysis: PubMatic (NASDAQ:PUBM) & Tempus AI (NASDAQ:TEM)

PubMatic (NASDAQ:PUBM) and Tempus AI (NASDAQ:TEM) are both computer and technology companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, dividends, institutional ownership, risk, valuation, analyst recommendations and earnings.

Institutional and Insider Ownership

64.3% of PubMatic shares are owned by institutional investors. 2.9% of PubMatic shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Profitability

This table compares PubMatic and Tempus AI’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
PubMatic	7.08%	6.92%	3.07%
Tempus AI	N/A	N/A	N/A

Valuation & Earnings

This table compares PubMatic and Tempus AI”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
PubMatic	$267.01 million	2.73	$8.88 million	$0.21	69.91
Tempus AI	N/A	N/A	N/A	N/A	N/A

PubMatic has higher revenue and earnings than Tempus AI.

Analyst Recommendations

This is a summary of recent recommendations and price targets for PubMatic and Tempus AI, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
PubMatic	0	3	4	0	2.57
Tempus AI	0	1	9	0	2.90

PubMatic presently has a consensus price target of $21.00, indicating a potential upside of 43.05%. Tempus AI has a consensus price target of $45.56, indicating a potential downside of 9.05%. Given PubMatic’s higher possible upside, research analysts plainly believe PubMatic is more favorable than Tempus AI.

Summary

PubMatic beats Tempus AI on 7 of the 9 factors compared between the two stocks.

About PubMatic

PubMatic, Inc., a technology company, engages in the provision of a cloud infrastructure platform that enables real-time programmatic advertising transactions for digital content creators, advertisers, agencies, agency trading desks, and demand side platforms worldwide. Its PubMatic SSP, a sell-side platform, used for the purchase and sale of digital advertising inventory for publishers and buyers. The company also provides solutions, including OpenWrap, a header bidding solution; Openwrap OTT, a prebid-powered unified bidding solution; Openwrap SDK, an enterprise-grade management tools and analytics; Connect, a solution that provides additional data and insights to publishers and buyers; Activate, which allows buyers to execute direct deals on its platform across publisher inventory; Convert, a commerce media solution; and Identity Hub, an ID management tool for publishers that leverages specialized technology?infrastructure?to simplify the complex alternative identifier marketplace. Its platform supports an array of ad formats and digital device types, including mobile app, mobile web, desktop, display, video, over-the-top (OTT), connected television, and media. The company was incorporated in 2006 and is based in Redwood City, California.

About Tempus AI

Tempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. Tempus AI Inc. is based in CHICAGO.